128 related articles for article (PubMed ID: 25044636)
41. Persistent hypogammaglobulinemia following mononucleosis in boys is highly suggestive of X-linked lymphoproliferative disease--report of three cases.
Hügle B; Suchowerskyj P; Hellebrand H; Adler B; Borte M; Sack U; Overberg-Schmidt US; Strnad N; Otto J; Meindl A; Schuster V
J Clin Immunol; 2004 Sep; 24(5):515-22. PubMed ID: 15359110
[TBL] [Abstract][Full Text] [Related]
42. Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gammaherpesvirus-68 and hypo-gammaglobulinemia.
Yin L; Al-Alem U; Liang J; Tong WM; Li C; Badiali M; Médard JJ; Sumegi J; Wang ZQ; Romeo G
J Med Virol; 2003 Nov; 71(3):446-55. PubMed ID: 12966553
[TBL] [Abstract][Full Text] [Related]
43. Natural killer T cells and X-linked lymphoproliferative syndrome.
Latour S
Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):510-4. PubMed ID: 17989527
[TBL] [Abstract][Full Text] [Related]
44. Two Clonally Distinct B-Cell Lymphomas Reveal the Diagnosis of XLP1 in a Male Child and His Asymptomatic Male Relatives: Case Report and Review of the Literature.
Iglesias Cardenas F; Agarwal AM; Vagher J; Maese L; Fluchel M; Afify Z
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1210-e1213. PubMed ID: 33448720
[TBL] [Abstract][Full Text] [Related]
45. X-linked Lymphoproliferative Disease Type 1 in a Patient With the p.Gly93Asp SH2D1A Gene Mutation and Hemophagocytic Lymphohistiocytosis.
de la Varga-Martínez R; Mora-López F; García-Cuesta D; Garrastazul-Sánchez MP; Quintero S; Rodríguez C; Sampalo A
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e483-e485. PubMed ID: 28816794
[TBL] [Abstract][Full Text] [Related]
46. Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP.
Hare NJ; Ma CS; Alvaro F; Nichols KE; Tangye SG
Int Immunol; 2006 Jul; 18(7):1055-65. PubMed ID: 16720617
[TBL] [Abstract][Full Text] [Related]
47. Skin lesions in a boy with X-linked lymphoproliferative disorder: comparison of 5 SH2D1A deletion cases.
Mejstríková E; Janda A; Hrusák O; Bucková H; Vlcková M; Hancárová M; Freiberger T; Ravcuková B; Vesely K; Fajkusová L; Kopecková L; Sumerauer D; Kabícková E; Sedivá A; Stary J; Sedlácek Z
Pediatrics; 2012 Feb; 129(2):e523-8. PubMed ID: 22271700
[TBL] [Abstract][Full Text] [Related]
48. SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis.
Yang X; Miyawaki T; Kanegane H
Pediatr Int; 2012 Aug; 54(4):447-54. PubMed ID: 22672194
[TBL] [Abstract][Full Text] [Related]
49. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.
Nichols KE; Ma CS; Cannons JL; Schwartzberg PL; Tangye SG
Immunol Rev; 2005 Feb; 203():180-99. PubMed ID: 15661030
[TBL] [Abstract][Full Text] [Related]
50. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B.
Sylla BS; Murphy K; Cahir-McFarland E; Lane WS; Mosialos G; Kieff E
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7470-5. PubMed ID: 10852966
[TBL] [Abstract][Full Text] [Related]
51. Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency.
Soresina A; Lougaris V; Giliani S; Cardinale F; Armenio L; Cattalini M; Notarangelo LD; Plebani A
Eur J Pediatr; 2002 Dec; 161(12):656-9. PubMed ID: 12447665
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency.
Eastwood D; Gilmour KC; Nistala K; Meaney C; Chapel H; Sherrell Z; Webster AD; Davies EG; Jones A; Gaspar HB
Clin Exp Immunol; 2004 Sep; 137(3):584-8. PubMed ID: 15320910
[TBL] [Abstract][Full Text] [Related]
53. X-linked lymphoproliferative syndromes and related autosomal recessive disorders.
Veillette A; Pérez-Quintero LA; Latour S
Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):614-22. PubMed ID: 24113228
[TBL] [Abstract][Full Text] [Related]
54. The abnormal gene in X-linked lymphoproliferative syndrome.
Sullivan JL
Curr Opin Immunol; 1999 Aug; 11(4):431-4. PubMed ID: 10448142
[TBL] [Abstract][Full Text] [Related]
55. [Clinical and gene research of X-linked lymphoproliferative disease in a Chinese family].
Zhu DX; Du J; Lan HK; Yu L; Feng ZC
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):244-8. PubMed ID: 17425868
[TBL] [Abstract][Full Text] [Related]
56. Structural characterization of disease-causing mutations on SAP and the functional impact on the SLAM peptide: a molecular dynamics approach.
Chandrasekaran P; Rajasekaran R
Mol Biosyst; 2014 Jul; 10(7):1869-80. PubMed ID: 24770789
[TBL] [Abstract][Full Text] [Related]
57. Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save lives.
Sperl D; Benesch M; Urban C; Lackner H; Sovinz P; Speicher MR; Uhrig S; Schwarzbraun T; Schwinger W; zur Stadt U; Beutel K; Janka G; Scarpatetti M; Seidel MG
Klin Padiatr; 2012 Oct; 224(6):386-9. PubMed ID: 23143765
[TBL] [Abstract][Full Text] [Related]
58. Absence of SLAM mutations in EBV-associated lymphoproliferative disease patients.
Ferrand V; Li C; Romeo G; Yin L
J Med Virol; 2003 May; 70(1):131-6. PubMed ID: 12629654
[TBL] [Abstract][Full Text] [Related]
59. Fatal hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection in a patient with a novel mutation in the signaling lymphocytic activation molecule-associated protein.
Halasa NB; Whitlock JA; McCurley TL; Smith JA; Zhu Q; Ochs H; Dermody TS; Crowe JE
Clin Infect Dis; 2003 Nov; 37(10):e136-41. PubMed ID: 14583885
[TBL] [Abstract][Full Text] [Related]
60. Case report: EBV-related eye orbits and sinuses lymphohistiocytic infiltration responsive to rituximab in a patient with X lymphoproliferative syndrome type 1.
Giardino G; Lanni V; Mascolo M; Russo D; Cirillo E; Romano R; Cillo F; Grilli L; Prencipe MR; Iuliano A; Uccello G; De Fusco C; Menna G; Scalia G; Portella G; Pignata C
Front Immunol; 2024; 15():1370991. PubMed ID: 38633254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
